Summary of Product Characteristics
last updated on the eMC:
20/09/2007
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 20/09/2007 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
|
| Date of revision of text on the SPC: 01/2007 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Section 7 (Marketing Authorisation Holder): change to sanofi-aventis.
|
|
Updated on 15/06/2007 and displayed until 20/09/2007
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
|
| Date of revision of text on the SPC: 01/2007 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
|
Change in section 7 from: -
Castlemead Healthcare Limited
20 Clanwilliam Terrace
to
Aventis Pharma Ltd
50 Kings Hill Avenue
Kings Hill
Or trading as
Sanofi-aventis
One Onslow Street
Guildford
|
|
Updated on 27/09/2006 and displayed until 15/06/2007
|
Reasons for adding or updating:
|
-
Addition of separate SPCs covering individual presentations
|
| Date of revision of text on the SPC: 07/2005 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
No changes to the text of the SPC has been made. Previous SPC on the eMC included all three Vallergan presentations on the one . This SPC has been entered due to the addition of separate SPCs covering individual presentations within the range of Vallergan.
|
|
